GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Genomma Lab Internacional SAB de CV (MEX:LABB) » Definitions » 5-Year Yield-on-Cost %

Genomma Lab InternacionalB de CV (MEX:LABB) 5-Year Yield-on-Cost % : 3.73 (As of Sep. 26, 2024)


View and export this data going back to 2008. Start your Free Trial

What is Genomma Lab InternacionalB de CV 5-Year Yield-on-Cost %?

Genomma Lab InternacionalB de CV's yield on cost for the quarter that ended in Jun. 2024 was 3.73.


The historical rank and industry rank for Genomma Lab InternacionalB de CV's 5-Year Yield-on-Cost % or its related term are showing as below:

MEX:LABB' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 3.55   Med: 5.12   Max: 11.6
Current: 3.73


During the past 13 years, Genomma Lab InternacionalB de CV's highest Yield on Cost was 11.60. The lowest was 3.55. And the median was 5.12.


MEX:LABB's 5-Year Yield-on-Cost % is ranked better than
69.41% of 510 companies
in the Drug Manufacturers industry
Industry Median: 2.175 vs MEX:LABB: 3.73

Competitive Comparison of Genomma Lab InternacionalB de CV's 5-Year Yield-on-Cost %

For the Drug Manufacturers - Specialty & Generic subindustry, Genomma Lab InternacionalB de CV's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genomma Lab InternacionalB de CV's 5-Year Yield-on-Cost % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Genomma Lab InternacionalB de CV's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Genomma Lab InternacionalB de CV's 5-Year Yield-on-Cost % falls into.



Genomma Lab InternacionalB de CV 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Genomma Lab InternacionalB de CV is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Genomma Lab InternacionalB de CV  (MEX:LABB) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Genomma Lab InternacionalB de CV 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Genomma Lab InternacionalB de CV's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Genomma Lab InternacionalB de CV Business Description

Traded in Other Exchanges
Address
Avenida Antonio Dovali Jaime, Number 70, Tower C, Floor 2, Office A. Colonia Santa Fe, Del. Alvaro Obregon, Mexico, MEX, MEX, CP 01210
Genomma Lab Internacional SAB de CV is a specialty and generic drug manufacturer. The company's stated goal is to improve and preserve the health and well-being of people through innovative, safe, and effective products. Genomma operates a wide variety of brands to serve different consumer needs, including pregnancy, pain medication, and deodorant. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Genomma Lab InternacionalB de CV Headlines

No Headlines